Three 2BCured Researchers to Present at 7th European GRIN Conference​

Three 2BCured Researchers to Present at 7th European GRIN Conference We are thrilled to share that three scientists from the 2BCured network – Dr. Shai Berlin, Dr. Shani Stern, and Dr. Avi Schroeder – have been invited as speakers at GRIN Europe’s upcoming 7th GRIN Conference. This is a meaningful recognition of their innovative efforts […]

Behind the Breakthrough: Patent FAQ

Behind the Breakthrough: Patent FAQ 1. What was just announced?Dr. Shai Berlin, an NMDA receptor expert part of a collaborative network of laboratories supported by the 2BCured Foundation, made an important scientific breakthrough relating to GRIN2B-Related Neurodevelopmental Disorder resulting in the issuance of a patent. 2. How does the therapy work? The therapy uses a […]

Innovation in Motion: GRIN2B Patent Marks Key Advancement

Innovation in Motion: GRIN2B Patent Marks Key Advancement Professor Shai Berlin, a lead scientist with the 2BCured research team, announced the issuance of a patent for a novel gene therapy aimed at treating GRIN2B-Related Neurodevelopmental Disorder. The patent involves use of a recombinant adeno-associated virus (AAV) vector capable of delivering a full-length, healthy GRIN2B gene […]